TSVT: 2seventy bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 259.60
Enterprise Value ($M) 188.35
Book Value ($M) 210.81
Book Value / Share 4.03
Price / Book 1.23
NCAV ($M) -81.45
NCAV / Share -1.56
Price / NCAV -3.19

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 4.67
Current Ratio 4.67

Balance Sheet (mrq) ($M)
Current Assets 187.26
Assets 479.51
Liabilities 268.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 37.86
Operating Income -105.54
Net Income -57.25

Cash Flow Statement (mra) ($M)
Cash From Operations -85.00
Cash from Investing 80.76
Cash from Financing 0.42

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-18 13G Beryl Capital Management LLC 8.10
03-17 13G/A Kynam Capital Management, LP 0.00 -100.00
11-06 13G/A Morgan Stanley 5.50 -40.76

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 195,438 1,070,323 18.26
2025-04-02 59,306 407,656 14.55
2025-04-01 116,815 793,756 14.72
2025-03-31 255,068 1,120,807 22.76

(click for more detail)

Similar Companies
TNYA – Tenaya Therapeutics, Inc. TRML – Tourmaline Bio, Inc.
TSHA – Taysha Gene Therapies, Inc. TWST – Twist Bioscience Corporation
TXMD – TherapeuticsMD, Inc.


Financial data and stock pages provided by
Fintel.io